Your browser doesn't support javascript.
loading
Simvastatin attenuates acute lung injury by activation of A2B adenosine receptor.
Li, Hong-Xia; Liang, Xiao-Yan; Wu, Jiong-He; Yuan, Ya-Ping; Gao, Yue; Cai, Shao-Hua.
Affiliation
  • Li HX; Department of Respiratory and Critical Care Medicine, The Second Medical Center, National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing 100853, China.
  • Liang XY; Department of Respiratory Medicine in Special Wards, Chinese PLA General Hospital, Beijing 100853, China.
  • Wu JH; Department of Respiratory and Critical Care Medicine, The Second Medical Center, National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing 100853, China.
  • Yuan YP; Department of Respiratory and Critical Care Medicine, The Second Medical Center, National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing 100853, China.
  • Gao Y; Beijing Institute of Radiation Medicine, AMMS, Haidian, Beijing 100039, China. Electronic address: gaoyue@bmi.ac.cn.
  • Cai SH; Department of Respiratory Medicine in Special Wards, Chinese PLA General Hospital, Beijing 100853, China. Electronic address: csh301@163.com.
Toxicol Appl Pharmacol ; 422: 115460, 2021 07 01.
Article in En | MEDLINE | ID: mdl-33774062

Full text: 1 Database: MEDLINE Main subject: Simvastatin / Receptor, Adenosine A2B / Acute Lung Injury / Adenosine A2 Receptor Agonists / Lung Type of study: Prognostic_studies Limits: Animals Language: En Journal: Toxicol Appl Pharmacol Year: 2021 Type: Article Affiliation country: China

Full text: 1 Database: MEDLINE Main subject: Simvastatin / Receptor, Adenosine A2B / Acute Lung Injury / Adenosine A2 Receptor Agonists / Lung Type of study: Prognostic_studies Limits: Animals Language: En Journal: Toxicol Appl Pharmacol Year: 2021 Type: Article Affiliation country: China